Medicover AB's EBIT per Share for the
three
months ended in Mar. 2026 was kr3.20.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr12.00.
During the past 12 months, the average EBIT per Share Growth Rate of Medicover AB was 84.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 38.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 8.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 18.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medicover AB's EBIT per Share or its related term are showing as below:
LTS:0RPS'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -15.6 Med: 20.3 Max: 62
Current: 38.9
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Medicover AB was 62.00% per year. The lowest was -15.60% per year. And the median was 20.30% per year.
LTS:0RPS's 3-Year EBIT Growth Rate is ranked better than 79.89% of 527
companies
in the Healthcare Providers & Services industry
Industry Median: 12.1
vs LTS:0RPS: 38.90
Medicover AB's EBIT for the
three
months ended in Mar. 2026 was kr487 Mil.
Medicover AB (LTS:0RPS) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medicover AB EBIT per Share Related Terms
Medicover AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medicover AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr12.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicover AB (LTS:0RPS) has a EBIT per Share of kr12.00 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medicover AB and its competitors. According to the industry distribution chart, Medicover AB ranks #106 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 20.1%.
Is Medicover AB's EBIT per Share too high?
Medicover AB's current EBIT per Share is kr12.00. Based on the distribution chart, Medicover AB ranks #106 out of 527 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medicover AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #106 out of 527 companies for EBIT per Share. This places Medicover AB in the top 20% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current EBIT per Share is kr12.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.91, compared to a current price of kr230.00 — trading 2.1% below its estimated fair value. The current EBIT per Share is kr12.00. Medicover AB's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current EBIT per Share is kr12.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (LTS:0RPS) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued.
The current stock price of kr230.00 is trading 2.1% below its estimated GF Value™ of kr234.91.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for LTS:0RPS:
EBIT per Share: kr12.00
GF Value™: kr234.91 vs. price of kr230.00 (2.1% below fair value)
No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
90GF Score
Get the complete analysis for LTS:0RPS
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RPS has been successfully added to your 
